Now, Seriously, What's So Tricky About Cholesterol?

It's an essential molecule in our body that goes terribly misunderstood.

This article is the final part of a 3 part miniseries. The first 2 parts can be found at:

Medical science has been talking about cholesterol and its links to heart disease for years. People who are at risk of heart failure are invariably prescribed medicines such as statins by medical doctors to lower the cholesterol levels in their blood, in the hope that they would be able to protect one’s body against heart attacks and/or strokes as well.

We first have to look at the mechanism behind the synthesis and the elimination of cholesterol from the body.

The liver cells are the main synthesisers of cholesterol. However, as cholesterol is a fatty molecule, it isn’t going to be transported by the blood really well. As an analogy, we can look at what happens when we mix oil and water. The oil tends to separate out from the water upon standing, and we see it floating on top of the water. They become two distinct liquids that are, in solution chemistry parlance, immiscible.

Immiscibility poses a problem. It won’t be easy for an essential ingredient be transported through the blood to the cell if it’s going to separate out from the blood into its own distinct liquid entity before even reaching the cell.

That’s when the lipoprotein comes in. A lipoprotein contains a hydrophobic (oil-loving) core and a hydrophilic (water-loving) exterior. In that way, the cholesterol particles can be packed into the core of the lipoprotein and zipped up, much like a backpack does for a student in carrying their textbooks to and from school.

The lipoprotein can then enter the blood, go to a cell, release some cholesterol and voila. The cholesterol transportation to the cell is completed.

Now, as oil floats on water, cholesterol will also float on water. We can say, again, in chemical engineering parlance, that the oil is of a lower density than water.

As a result, the density of the lipoprotein taking on a full load of cholesterol at the liver decreases, relative to the density of the blood.

In that way, we can see the development of two key medical terms: High Density Lipoproteins (HDL) and Low Density Lipoproteins (LDL), which are somehow labelled as “good” cholesterol and “bad” cholesterol even though they are mainly just the cholesterol couriers running through the body to deliver fresh cholesterol for cell synthesis and remove old cholesterol for disposal.

As the LDL distributes its cholesterol cargo to all the cells, its density increases — hence we can call it high density lipoprotein (HDL). It can take some waste cholesterol from the cells back to the liver for disposal, but the amount of waste cholesterol that HDL carries is much less than the amount of fresh cholesterol that LDL carries.

Hence HDL’s density will be higher than LDL’s - it’s a consideration of how fully packed with cholesterol a lipoprotein is.

The liver then processes the cholesterol into bile salts, which are then dumped into the stool for excretion. Part of these bile salts can be reabsorbed back by the intestines into the blood.

Unfortunately, the longer the stools stay in the intestines, the more cholesterol will be re-absorbed and sent back out into the blood via the LDL. Poor liver function may also reduce the rate of bile salt processing and cause cholesterol accumulation too.

When more cholesterol gets re-absorbed, every other HDL protein will eventually accumulate enough cholesterol to become LDL. This is the key term that many cardiologists will tell their patients to lower.

Because otherwise, blood cholesterol levels would be likely to increase further.

Statin drugs have been prescribed by doctors to keep blood cholesterol levels under control. More than 35 million Americans are currently using statins for such purposes.

Statins block the synthesis of mevalonate by the HmG-CoA reductase (HmG-CR) enzyme by inhibiting the activity of HmG-CR. Mevalonate is a significant intermediary in the synthesis of cholesterol.

Hence, we’re looking at a reduction in the synthesis of fresh cholesterol.

On the surface, it looks fantastic. People with high blood cholesterol ought to block the synthesis of new cholesterol. However, when we’re looking at a dynamic equilibrium in balancing out the mass cholesterol in our bodies: